Top entities: United States — Food and Drug Administration, United States, United States — National Institute of Environmental Health Sciences.

What category does this event fall under?

Regulatory — classified as safety study.

What is the sentiment of coverage?

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

What were the key actions taken?

United States — Food and Drug Administration published study · United States — Food and Drug Administration proposed guidelines

Is this event still developing?

This is an active story, last updated Jul 10, 2026. Coverage continues to evolve.

Regulatory safety study

FDA tampon metal safety study

Q: When did this event occur?

First reported Jul 07, 2026; last updated Jul 10, 2026.

Q: What is the market impact?

General. The FDA's conclusion that tampon metals pose no health risk is likely to reassure consumers and tampon manufacturers, avoiding potential market disruption or liability concerns.

Analysis based on 6 articles · First reported Jul 07, 2026 · Last updated Jul 10, 2026

Sentiment

Attention

Articles

Market Impact

General

Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Market Impact

The FDA's conclusion that tampon metals pose no health risk is likely to reassure consumers and tampon manufacturers, avoiding potential market disruption or liability concerns. The proposed guidelines may increase compliance costs for manufacturers but are unlikely to significantly impact the market.

feminine hygiene products medical devices

Event Summary

The U.S. United States — Food and Drug Administration (FDA) published a study in Toxicological Sciences confirming trace amounts of metals like arsenic, cadmium, and lead in tampons, but concluded that levels released during normal use are too low to pose a health risk. The study tested 11 tampons from six brands, detecting 19 metals. This follows a 2024 study that raised concerns. The FDA also proposed guidelines for contaminant testing and labeling transparency. The United States — National Institute of Environmental Health Sciences noted limited long-term safety data on feminine hygiene products.

Key Actions

80 United States — Food and Drug Administration published study

60 United States — Food and Drug Administration proposed guidelines

Entities Involved

govactor

United States — Food and Drug Administration

The FDA conducted the study and concluded tampon metals are safe, reinforcing its regulatory role. It also proposed new guidelines for tampon manufacturers.

Importance 100.0 Sentiment 0.0

cnt

United States

The FDA is a U.S. agency, and the study affects U.S. consumers and tampon manufacturers. The U.S. market for tampons remains stable.

Importance 50.0 Sentiment 0.0

govactor

United States — National Institute of Environmental Health Sciences

A health scientist administrator from the NIEHS commented on the lack of long-term safety data on feminine hygiene products, but the institute was not directly involved in the study.

Importance 20.0 Sentiment 0.0

Relationships

United States — Food and Drug Administration related ↔ United States

ERGEN INTELLIGENCE

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard